• LAST PRICE
    29.5700
  • TODAY'S CHANGE (%)
    Trending Up1.0700 (3.7544%)
  • Bid / Lots
    14.0000/ 1
  • Ask / Lots
    47.2300/ 2
  • Open / Previous Close
    29.0100 / 28.5000
  • Day Range
    Low 27.1000
    High 29.9900
  • 52 Week Range
    Low 9.4100
    High 29.9900
  • Volume
    216,915
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Wednesday's close: 28.5
TimeVolumeAVTE
09:32 ET123928.685
09:41 ET20028.41
09:43 ET10028.69
09:45 ET10028.385
09:48 ET15028.5232
09:50 ET30828.84
09:52 ET10028.97
09:54 ET10028.64
09:57 ET10028.71
10:01 ET3723828.55
10:03 ET136328.46
10:06 ET23028.505
10:08 ET20028.46
10:10 ET20028.51
10:15 ET130228.15
10:17 ET30028.13
10:19 ET10028.15
10:21 ET20028.04
10:24 ET90027.71
10:26 ET30027.56
10:30 ET30027.64
10:32 ET11927.5573
10:33 ET10027.57
10:35 ET50227.745
10:37 ET50027.73
10:39 ET10027.62
10:44 ET110027.61
10:46 ET10027.65
10:48 ET10827.6
10:50 ET211328
10:55 ET23827.915
10:57 ET40027.88
11:00 ET10027.99
11:02 ET133027.9
11:04 ET112027.69
11:08 ET20027.485
11:11 ET10027.39
11:13 ET20027.48
11:18 ET20027.6
11:20 ET10027.6
11:27 ET343328
11:29 ET70028
11:44 ET50027.75
11:45 ET50027.82
11:47 ET10027.7331
12:02 ET10027.72
12:03 ET10027.855
12:14 ET80028
12:21 ET10027.97
12:25 ET20027.88
12:30 ET10027.76
12:34 ET20027.76
12:36 ET20027.765
12:39 ET40027.6
12:43 ET40027.52
12:48 ET20027.375
12:50 ET10027.8699
12:52 ET10027.505
12:54 ET10027.49
12:56 ET10027.405
12:59 ET10027.41
01:01 ET30027.63
01:06 ET20027.31
01:10 ET10027.285
01:12 ET10027.27
01:14 ET105027.165
01:15 ET20027.235
01:17 ET10027.1
01:21 ET153027.445
01:33 ET20027.59
01:35 ET10027.38
01:37 ET10027.335
01:42 ET10027.35
01:44 ET30027.62
01:46 ET10027.355
01:51 ET10027.4
01:55 ET10027.4325
01:57 ET10027.4325
02:02 ET10027.375
02:04 ET90027.495
02:06 ET40027.62
02:11 ET10027.39
02:33 ET20027.605
02:40 ET10027.745
02:42 ET176727.77
02:54 ET30027.98
02:58 ET3120028
03:02 ET828228.58
03:03 ET30028.62
03:07 ET10028.695
03:09 ET30028.71
03:16 ET10028.71
03:20 ET50028.75
03:25 ET10028.985
03:27 ET300729.05
03:30 ET244128.82
03:32 ET40028.94
03:36 ET160029
03:38 ET60028.87
03:39 ET160029
03:41 ET224428.98
03:43 ET50029.195
03:45 ET50029.16
03:48 ET70029.205
03:50 ET60029.21
03:52 ET240029.05
03:54 ET308529.22
03:56 ET898029.45
03:57 ET339929.48
03:59 ET2966329.57
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesAVTE
Aerovate Therapeutics Inc
794.1M
-10.3x
---
United StatesNKTX
Nkarta Inc
778.1M
-4.5x
---
United StatesPRME
Prime Medicine Inc
810.8M
-3.2x
---
United StatesHLVX
Hillevax Inc
776.3M
-5.5x
---
United StatesPRAX
Praxis Precision Medicines Inc
783.7M
-2.6x
---
United StatesCGEM
Cullinan Oncology Inc
763.6M
-4.6x
---
As of 2024-03-28

Company Information

Aerovate Therapeutics Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing drugs that meaningfully improve the lives of patients with rare cardiopulmonary disease. Its initial focus is on advancing AV-101, its dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension (PAH), a devastating disease impacting approximately 70,000 people in the United States and Europe. Oral imatinib also demonstrated statistically significant improvement on the primary endpoint, six-minute walk distance, and multiple secondary hemodynamic endpoints in PAH patients. AV-101, delivered using a dry powder inhaler, is designed to provide lung concentrations at or above those observed with the oral dose while limiting systemic levels of the drug. PAH is an orphan disease with unmet medical needs and is characterized by high pressure in the vessels transporting blood from the right side of the heart to the lungs.

Contact Information

Headquarters
930 Winter Street, Suite M-500WALTHAM, MA, United States 02451
Phone
617-443-2400
Fax
302-655-5049

Executives

Independent Chairman of the Board
Mark Iwicki
President, Chief Operating Officer, Secretary
Benjamin Dake
Chief Executive Officer, Director
Timothy Noyes
Chief Financial Officer, Treasurer
George Eldridge
Senior Vice President - Development Operations
Susan Fischer

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$794.1M
Revenue (TTM)
$0.00
Shares Outstanding
27.9M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
---
EPS
$-2.87
Book Value
$3.94
P/E Ratio
-10.3x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.